MYRIAD GENETICS, INC. Debt Securities, Available-for-sale
MYRIAD GENETICS, INC. (MYGN) had Debt Securities, Available-for-sale of $0 as of 2024-12-31, per its 10-K filed 2025-02-28.
Financial Statements › Balance Sheet › Assets
us-gaap:AvailableForSaleSecuritiesDebtSecurities · last filed 2025-02-28
- 2024-12-31: Debt Securities, Available-for-sale $0.00.
- 2024-09-30: Debt Securities, Available-for-sale $0.00.
- 2020-06-30: Debt Securities, Available-for-sale $254.80M.
- 2020-03-31: Debt Securities, Available-for-sale $224.30M.
| Period end | Debt Securities, Available-for-sale |
|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-02-28 |
| 2024-09-30 | $0.00 10-Q · filed 2024-11-08 |
| 2020-06-30 | $254.80M 10-K · filed 2020-08-13 |
| 2020-03-31 | $224.30M 10-Q · filed 2020-05-06 |
| 2019-12-31 | $189.20M 10-Q · filed 2020-02-07 |
| 2019-09-30 | $194.10M 10-Q · filed 2019-11-06 |
| 2019-06-30 | $191.80M 10-K · filed 2020-08-13 |
| 2019-03-31 | $190.00M 10-Q · filed 2019-05-08 |
| 2018-12-31 | $195.30M 10-Q · filed 2019-02-06 |
| 2018-06-30 | $211.30M 10-K · filed 2019-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |